Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Thimet Oligopeptidase Biochemical and Biological Significances: Past, Present, and Future Directions

Texto completo
Autor(es):
Ferro, Emer S. [1, 2] ; Gewehr, Mayara C. F. [1] ; Navon, Ami [2]
Número total de Autores: 3
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Biomed Sci Inst, Pharmacol Dept, BR-05508000 Sao Paulo, SP - Brazil
[2] Weizmann Inst Sci, Dept Biol Regulat, IL-7610001 Rehovot - Israel
Número total de Afiliações: 2
Tipo de documento: Artigo de Revisão
Fonte: BIOMOLECULES; v. 10, n. 9 SEP 2020.
Citações Web of Science: 2
Resumo

Thimet oligopeptidase (EC 3.4.24.15; EP24.15, THOP1) is a metallopeptidase ubiquitously distributed in mammalian tissues. Beyond its previously well characterized role in major histocompatibility class I (MHC-I) antigen presentation, the recent characterization of the THOP1 C57BL6/N null mice (THOP1(-/-)) phenotype suggests new key functions for THOP1 in hyperlipidic diet-induced obesity, insulin resistance and non-alcoholic liver steatosis. Distinctive levels of specific intracellular peptides (InPeps), genes and microRNAs were observed when comparing wild type C57BL6/N to THOP1(-/-)fed either standard or hyperlipidic diets. A possible novel mechanism of action was suggested for InPeps processed by THOP1, which could be modulating protein-protein interactions and microRNA processing, thus affecting the phenotype. Together, research into the biochemical and biomedical significance of THOP1 suggests that degradation by the proteasome is a step in the processing of various proteins, not merely for ending their existence. This allows many functional peptides to be generated by proteasomal degradation in order to, for example, control mRNA translation and the formation of protein complexes. (AU)

Processo FAPESP: 16/04000-3 - Farmacologia de oligopeptidases e peptídeos intracelulares
Beneficiário:Emer Suavinho Ferro
Modalidade de apoio: Auxílio à Pesquisa - Temático